Human leukocyte antigen-A2- and A24-restricted CTL peptides derived from SOX6 have been identified, and glioma patient lymphocytes stimulated with these peptides are capable of inducing glioma-specific CTLs [16]. The gene discussed is SOX6; the disease is central nervous system cancer.